If acid reflux is a concern, patients should work closely with their doctor to find the best way to balance the benefits of semaglutide with any potential side effects
In a cohort study that was conducted in 2024 using TriNetX network, semaglutide was not associated with an increased risk of NAION in patients with type 2 diabetes compared with non-GLP-1RA antidiabetic medications but had an HR of 2.32 (95% CI, 0.60-8.97)
Whether you choose sublingual or injectable forms through PlexusDx's licensed compounding pharmacies, genetic insight combined with baseline biomarkers and close provider monitoring supports safer, more targeted treatment
G., Motsinger-Reif, A., Fiehn, O., Bottrel, N., Drevets, W
Typically, semaglutide doses are increased every four weeks if the medication is well tolerated